Tejara Capital LTD Kiniksa Pharmaceuticals, Ltd. Transaction History

Tejara Capital LTD

  • $210 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$17.63 - $21.74 $925,575 - $1.14 Million
-52,500 Reduced 55.18%
42,649 $841 Million
Q4 2023

Feb 12, 2024
BUY
$14.37 - $19.07 $864,341 - $1.15 Million
60,149 Added 171.85%
95,149 $1.67 Billion
Q3 2023

Nov 15, 2023
BUY
$13.62 - $20.2 $476,700 - $707,000
35,000 New
35,000 $608 Million
Q2 2023

Aug 11, 2023
SELL
$10.44 - $16.48 $152,100 - $240,097
-14,569 Reduced 30.04%
33,931 $478 Million
Q1 2023

May 12, 2023
BUY
$10.7 - $15.79 $518,949 - $765,815
48,500 New
48,500 $522 Million

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $751M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email